The Latest Cardiac and Vascular News
MARLBOROUGH, Mass., Nov. 29, 2018 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced completed enrollment in a trial to evaluate its next-generation HeartLight® X3 Endoscopic Ablation System. A total of 60 patients have been treated in this pivotal confirmatory trial with a one-month […]
LAGUNA HILLS, Calif., Nov. 28, 2018 /PRNewswire/ — Adagio Medical, Inc., developer of the iCLAS™ technology, the company’s ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias, announces updates to its ongoing cryoablation study for Persistent Atrial Fibrillation (PsAF). The study is currently being conducted at two clinical sites […]
CHICAGO–(BUSINESS WIRE)–Canon Medical Systems USA, Inc. is showcasing its premium Aplio™ i-series ultrasound platform with the deepest penetration available on the market at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, November 25 – 30, 2018 (Booth #1938, South Level 3). The Aplio i-series platform, a highly advanced and scalable […]
CALGARY, Alberta, Nov. 28, 2018 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today the recent publication of an article titled: “Apabetalone downregulates factors and pathways associated with vascular calcification” in Atherosclerosis, the official peer-reviewed scientific journal of the European Atherosclerosis Society. “Apabetalone and its unique mechanism […]
TEL AVIV, Israel, Nov. 28, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that its novel CGuard™ Embolic Prevention System (EPS) has been granted regulatory approval […]
Santa Monica, CA, Nov. 28, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company formed a Clinical Advisory Board to complement existing scientific […]
ANCHORAGE, Alaska, Nov. 27, 2018 /PRNewswire/ — Alaska Heart & Vascular Institute (AHVI) is pleased to announce the addition of Carson S. Webb, M.D. to the Mat-Su clinic in Palmer, AK. Dr. Webb graduated with a degree in medicine from the University of South Alabama in 2000. He specializes in percutaneous coronary, peripheral arterial, and peripheral venous interventions. […]
BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 26, 2018 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced a registered underwritten public offering of its American Depositary Shares (“ADSs”). All of the shares in the proposed offering are to be sold by Amarin. The offering is subject to market conditions, […]
Santa Monica, CA, Nov. 27, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has signed an agreement with Texas Cardiac Arrhythmia […]
PHOENIX–(BUSINESS WIRE)–Innovative Health, a national leader in medical device reprocessing for the cardiology sector, announced it has received FDA clearances to reprocess the Advisor FL Circular Mapping Catheter, Medtronic’s Torqr™ and Marinr™, and Biosense Webster’s DECANAV. Three of these clearances were received within the last month alone. Innovative Health has already […]
